Market Place
Sourcing Support
MGB Biopharma - Successful End-of-Phase 2 Meeting with FDA for MGB-BP-3
26 Jan 2021 //
PRNEWSWIRE
MGB Biopharma Announces Successful Outcome From Ph II Study with MGB-BP-3
19 May 2020 //
PR NEWSWIRE
MGB Biopharma Announces Successful Outcome From PhII Study with MGB-BP-3
18 May 2020 //
PRNEWSWIRE
MGB Biopharma reveals positive mid-stage diarrhoea data
11 Oct 2019 //
PHARMATIMES
MGB tops up cash pool to wrap up antibiotic phase 2a
30 Aug 2019 //
FIERCE BIOTECH
Catalent Accelerates Formulation and Supply for MGB Biopharma Candidate
26 Apr 2019 //
CONTRACTPHARMA
MGB Biopharma - FDA and Health Canada Clear IND/CTA Applications for MGB-BP-3
24 Jan 2019 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.